Snow Ellen has filed 4 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 149300 shares of Akebia Therapeutics, Inc. ($AKBA) on January 31, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Snow Ellen | SVP, CFO and Treasurer | A | Common Stock | 149300 | $0.00 | 519,300.0000 | 187,465,448 | 40.35% | 0.08% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Snow Ellen | SVP, CFO and Treasurer | A | Stock Option (Right to buy) | 224000 | $0.00 | 224,000.0000 | 187,465,448 | 9999.99% | 0.12% |
| July 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Snow Ellen | SVP, CFO and Treasurer | A | Common Stock | 370000 | $0.00 | 370,000.0000 | 0 | 9999.99% | 0.00% |
| July 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Snow Ellen | SVP, CFO and Treasurer | A | Stock Option (Right to buy) | 560000 | $0.00 | 560,000.0000 | 0 | 9999.99% | 0.00% |